CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Ipratropium Bromide

异丙托溴铵 杂质对照品Ipratropium Bromide Impurities

EP27 个杂质条目27 impurity entries

本页汇总 异丙托溴铵 的 27 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 27 impurity reference standards of Ipratropium Bromide with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 异丙托溴铵(Ipratropium Bromide)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment of a rapid and validated stability-indicating UPLC-PDA method for concurrent quantification of impurity profiling and an assay of ipratropium bromide and salbutamol sulfate in inhalation dosage form
    Annales pharmaceutiques francaises · 2023 · Kondra S et al.  ·  PMID 36126754  ·  DOI
  2. 杂质研究Impurity studiesDevelopment and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution
    Journal of pharmaceutical and biomedical analysis · 2010 · Kasawar GB, Farooqui M  ·  PMID 20045275  ·  DOI
  3. 杂质研究Impurity studiesDevelopment and validation of a stability-indicating high-performance liquid chromatography method for the simultaneous determination of albuterol, budesonide, and ipratropium bromide in compounded nebulizer solutions
    Journal of AOAC International · 2011 · Blewett AJ et al.  ·  PMID 21391487
  4. 分析方法Analytical MethodsEco-friendly cucurbituril-based potentiometric sensors for selective quantification of ipratropium bromide in pharmaceuticals and human plasma
    Analytical and bioanalytical chemistry · 2026 · Tawfik SA et al.  ·  PMID 41430000  ·  DOI
  5. 分析方法Analytical MethodsEcofriendly colorimetric set-up coupled with mathematical filtration strategy for simultaneous determination of ipratropium and fenoterol in their novel anti-asthmatic metered dose inhaler
    BMC chemistry · 2025 · Ali SN et al.  ·  PMID 39923075  ·  DOI

异丙托溴铵 —— 原料药与杂质对照品Ipratropium Bromide — drug substance & impurities

共 28 个条目(含原料药本体)28 items incl. the drug substance
Ipratropium Bromide structure
EP原料药 APIAPI
异丙托溴铵Ipratropium Bromide
Ipratropium Bromide
CAS No.22254-24-6
Chemical FormulaC20H30NO3+·Br-
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 1 (Ipratropium Bromide EP Impurity A Bromide) structure
EPA
异丙托溴铵杂质1 (异丙托溴铵EP杂质A 溴化物)Ipratropium Bromide Impurity 1 (Ipratropium Bromide EP Impurity A Bromide)
Ipratropium Bromide Impurity 1 (Ipratropium Bromide EP Impurity A Bromide)
CAS No.58005-18-8
Chemical FormulaC11H22NO+·Br-
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 2 (Ipratropium Bromide EP Impurity B Bromide) (Mixture of Enantiomers) structure
EPB
异丙托溴铵杂质2 (异丙托溴铵EP杂质B 溴化物) (对映异构体混合物)Ipratropium Bromide Impurity 2 (Ipratropium Bromide EP Impurity B Bromide) (Mixture of Enantiomers)
Ipratropium Bromide Impurity 2 (Ipratropium Bromide EP Impurity B Bromide) (Mixture of Enantiomers)
CAS No.58073-59-9
Chemical FormulaC20H30NO3+·Br-
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 3 (Ipratropium Bromide EP Impurity C) structure
EPC
异丙托溴铵杂质3 (异丙托溴铵EP杂质C)Ipratropium Bromide Impurity 3 (Ipratropium Bromide EP Impurity C)
Ipratropium Bromide Impurity 3 (Ipratropium Bromide EP Impurity C)
CAS No.552-63-6
Chemical FormulaC9H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 4 (Ipratropium Bromide EP Impurity D) structure
EPD
异丙托溴铵杂质4 (异丙托溴铵EP杂质D)Ipratropium Bromide Impurity 4 (Ipratropium Bromide EP Impurity D)
Ipratropium Bromide Impurity 4 (Ipratropium Bromide EP Impurity D)
CAS No.492-38-6
Chemical FormulaC9H8O2
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 5 ((S)-Ipratropium EP Impurity E) structure
EPE
异丙托溴铵杂质5 ((S)-异丙托溴铵EP杂质E)Ipratropium Bromide Impurity 5 ((S)-Ipratropium EP Impurity E)
Ipratropium Bromide Impurity 5 ((S)-Ipratropium EP Impurity E)
CAS No.183626-76-8
Chemical FormulaC19H27NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 13 (Ipratropium Bromide EP Impurity E) (Mixture of Enantiomers) structure
EPE
异丙托溴铵杂质13 (异丙托溴铵EP杂质E) (对映异构体混合物)Ipratropium Bromide Impurity 13 (Ipratropium Bromide EP Impurity E) (Mixture of Enantiomers)
Ipratropium Bromide Impurity 13 (Ipratropium Bromide EP Impurity E) (Mixture of Enantiomers)
CAS No.22235-81-0
Chemical FormulaC19H27NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 6 (Ipratropium Bromide EP Impurity F Bromide) structure
EPF
异丙托溴铵杂质6 (异丙托溴铵EP杂质F 溴化物)Ipratropium Bromide Impurity 6 (Ipratropium Bromide EP Impurity F Bromide)
Ipratropium Bromide Impurity 6 (Ipratropium Bromide EP Impurity F Bromide)
CAS No.60018-35-1
Chemical FormulaC20H28NO2+·Br-
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 7 structure
7
异丙托溴铵杂质7Ipratropium Bromide Impurity 7
Ipratropium Bromide Impurity 7
CAS No.3423-25-4
Chemical FormulaC10H19NO
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 8 structure
8
异丙托溴铵杂质8Ipratropium Bromide Impurity 8
Ipratropium Bromide Impurity 8
CAS No.5894-79-1
Chemical FormulaC10H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 9 structure
9
异丙托溴铵杂质9Ipratropium Bromide Impurity 9
Ipratropium Bromide Impurity 9
CAS No.259092-15-4
Chemical FormulaC10H19NO
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 10 structure
10
异丙托溴铵杂质10Ipratropium Bromide Impurity 10
Ipratropium Bromide Impurity 10
CAS No.936485-91-5
Chemical FormulaC20H28NO2+·Br-
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 11 structure
11
异丙托溴铵杂质11Ipratropium Bromide Impurity 11
Ipratropium Bromide Impurity 11
CAS No.17838-69-6
Chemical FormulaC11H12O3
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 12 structure
12
异丙托溴铵杂质12Ipratropium Bromide Impurity 12
Ipratropium Bromide Impurity 12
CAS No.22235-74-1
Chemical FormulaC19H25NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 18 structure
18
异丙托溴铵杂质18Ipratropium Bromide Impurity 18
Ipratropium Bromide Impurity 18
CAS No.3979-14-4
Chemical FormulaC11H14O3
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 21 structure
21
异丙托溴铵杂质21Ipratropium Bromide Impurity 21
Ipratropium Bromide Impurity 21
CAS No.17812-46-3
Chemical FormulaC20H28BrNO2
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 23 structure
23
异丙托溴铵杂质23Ipratropium Bromide Impurity 23
Ipratropium Bromide Impurity 23
CAS No.3423-23-2
Chemical FormulaC10H19NO
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 27 structure
27
异丙托溴铵杂质27Ipratropium Bromide Impurity 27
Ipratropium Bromide Impurity 27
CAS No.59973-73-8
Chemical FormulaC19H28BrNO2
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 29 structure
29
异丙托溴铵杂质29Ipratropium Bromide Impurity 29
Ipratropium Bromide Impurity 29
CAS No.88607-15-2
Chemical FormulaC18H25NO2
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 30 structure
30
异丙托溴铵杂质30Ipratropium Bromide Impurity 30
Ipratropium Bromide Impurity 30
CAS No.54108-62-2
Chemical FormulaC16H14O3
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 31 structure
31
异丙托溴铵杂质31Ipratropium Bromide Impurity 31
Ipratropium Bromide Impurity 31
CAS No.40195-49-1
Chemical FormulaC17H16O3
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 33 structure
33
异丙托溴铵杂质33Ipratropium Bromide Impurity 33
Ipratropium Bromide Impurity 33
CAS No.101-97-3
Chemical FormulaC10H12O2
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 37 structure
37
异丙托溴铵杂质37Ipratropium Bromide Impurity 37
Ipratropium Bromide Impurity 37
CAS No.682327-75-9
Chemical FormulaC19H27NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 38 structure
38
异丙托溴铵杂质38Ipratropium Bromide Impurity 38
Ipratropium Bromide Impurity 38
CAS No.3424-21-3
Chemical FormulaC9H21N
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 44 structure
44
异丙托溴铵杂质44Ipratropium Bromide Impurity 44
Ipratropium Bromide Impurity 44
CAS No.24358-20-1
Chemical FormulaC20H30NO3+·Br-
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 47 structure
47
异丙托溴铵杂质47Ipratropium Bromide Impurity 47
Ipratropium Bromide Impurity 47
CAS No.51491-68-0
Chemical FormulaC9H7ClO
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 48 structure
48
异丙托溴铵杂质48Ipratropium Bromide Impurity 48
Ipratropium Bromide Impurity 48
CAS No.3133350-09-8
Chemical FormulaC9H7BrO
Purity>95%询价On request
10mg25mg50mg100mg
Ipratropium Bromide Impurity 49 structure
49
异丙托溴铵杂质49Ipratropium Bromide Impurity 49
Ipratropium Bromide Impurity 49
CAS No.2699874-72-9
Chemical FormulaC9H7FO
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

异丙托溴铵 —— 研究文献与合成路线Ipratropium Bromide — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 异丙托溴铵 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Ipratropium Bromide. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution
    Kasawar GB, Farooqui M · Journal of pharmaceutical and biomedical analysis · 2010 · 被引 14cited 14
  2. Development of a rapid and validated stability-indicating UPLC-PDA method for concurrent quantification of impurity profiling and an assay of ipratropium bromide and salbutamol sulfate in inhalation dosage form
    Kondra S, Pawar AKM, Bapuji AT, et al. · Annales pharmaceutiques francaises · 2023
  3. High-performance liquid chromatographic assay for the simultaneous determination of ipratropium bromide, fenoterol, salbutamol and terbutaline in nebulizer solution
    Jacobson GA, Peterson GM · Journal of pharmaceutical and biomedical analysis · 1994 · 被引 21cited 21
  4. Radioreceptor assay for determination of the antimuscarinic drug ipratropium bromide in man
    Ensinger HA, Wahl D, Brantl V · European journal of clinical pharmacology · 1987 · 被引 15cited 15

合成与制备工艺专利Synthesis & process patents

  1. Technical synthesis method for producing tiotropium bromide, ipratropium bromide or BEA2108
    SOBOTTA RAINER, RAPP ARIM W · 公开号 NZ541395NZ541395 · 2007

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

异丙托溴铵 杂质谱研究要点Ipratropium Bromide — impurity profiling notes

下面这些是拿到 异丙托溴铵 的 28 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 28 impurity entries for Ipratropium Bromide, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances